TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization

RADIATION2 trials

Sponsors

University of Miami

Conditions

Hepatocellular CarcinomaMetastatic Uveal MelanomaMetastatic Uveal Melanoma in the LiverUnresectable Hepatocellular Carcinoma

Phase 2

Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

RecruitingNCT06627244

University of MiamiMetastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver

Start: 2025-02-14End: 2031-02-17Target: 30Updated: 2026-02-23

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

RecruitingNCT06902246

University of MiamiHepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma

Start: 2026-05-01End: 2031-05-01Target: 30Updated: 2026-03-27